European Pharmaceutical Review
SEPTEMBER 22, 2022
Moreover, pharmaceutical manufacturing poses a huge detriment to the state of the planet’s ecosystem. Active pharmaceutical ingredients (APIs) are particularly impact intensive, soaking up a large quantity of resources in terms of heat, energy and water when being produced.
pharmaphorum
OCTOBER 26, 2022
And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. We try to have a very long-term orientation because we believe that aligns our objectives very well with the objectives of society and the patients we serve, and it makes us a stable business.”.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
SEPTEMBER 6, 2022
The pharmaceutical supply chain is a global and complex network that includes a wide range of stakeholders such as pharmaceutical manufacturers, wholesale distributors, and pharmacy benefit managers (PBM), to ensure efficient and timely delivery of medications to the patients.
PM360
JUNE 26, 2023
Patients struggle to get the necessary treatments, in some cases resulting in increased hospitalization and death. The end-to-end supply chain comprises material procurement, manufacturing, transportation, warehousing, and distribution. drug manufacturers to continue producing generic drugs. Over 300 drugs in the U.S.
European Pharmaceutical Review
JULY 21, 2023
What are the top three supply-related challenges facing pharmaceutical manufacturers? Hayat Biotech’s global supply chain, spanning distribution to 64 countries, entails the involvement of multiple suppliers, distributors, and contract manufacturing organisations.
Pharmaceutical Technology
JULY 28, 2022
Located in downtown Charleston, the Medical University of South Carolina trains approximately 3,000 students a year, with an emphasis on world-class patient care alongside groundbreaking research and innovation. Domestic market and transportation infrastructure.
Clarify Health
OCTOBER 26, 2021
By enrolling participants with a wide range of baseline characteristics, study populations will more accurately reflect the patients likely to take the drug if it is approved. Cancer patients treated in clinical trials live substantially longer than those not treated in trials and benefit from lower hospital readmissions. 2] Figure 1.
Expert insights. Personalized for you.
98 
Let's personalize your content